Related Experiment Video
Updated: Apr 4, 2026
06:41
Author Spotlight: Unveiling the Potential of Unpurified Recombinant AAVs in Cell Culture Research
Published on: October 20, 2023
4.4K
Adeno-associated Virus as a Mammalian DNA Vector
Max Salganik1, Matthew L Hirsch1, Richard Jude Samulski1
1Gene Therapy Center, Department of Pharmacology, University of North Carolina, Chapel Hill, NC.
Microbiology Spectrum
|September 10, 2015
Summary
Adeno-associated virus (AAV) vectors are a safe and efficient gene transfer platform for mammalian cells. Decades of research highlight their versatility in research and clinical applications, offering new hope for patients.
Area of Science:
- Virology
- Gene Therapy
- Biotechnology
Background:
- Adeno-associated virus (AAV) discovered nearly 50 years ago.
- AAV has evolved into a versatile vector system for research and clinical use.
- Natural serotypes and capsid variants offer diverse tissue tropisms and transduction efficiencies.
Purpose of the Study:
- To review the progress and applications of adeno-associated virus (AAV) vectors.
- To highlight the advancements in AAV vector technology for gene transfer.
- To discuss the potential and challenges of AAV in clinical settings.
Main Methods:
- Review of scientific literature on AAV discovery and development.
- Analysis of AAV serotype diversity and capsid engineering.
- Evaluation of AAV vector performance in research and clinical studies.
Main Results:
- AAV vectors demonstrate significant versatility due to diverse serotypes and variants.
- AAV has shown promise in clinical applications, offering therapeutic hope.
- AAV vectors are recognized as a leading platform for gene transfer in mammalian cells.
Conclusions:
- AAV vectors represent a safe and efficient gene transfer platform.
- Continued research into AAV biology and clinical optimization is ongoing.
- AAV holds significant promise as a tool for physicians and a therapeutic option for patients.
